Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Koethe, John R ^a,c   Blevins, Meridith ^b,c   Nyirenda, Christopher ^a,d   Kabagambe, Edmond K ^g   Shepherd, Bryan E ^c   Wester, C William ^b,c,e   Zulu, Isaac ^a,d   Chiasera, Janelle M ^g   Mulenga, Lloyd B ^a,d   Mwango, Albert ^f   Heimburger, Douglas C ^a,b,c,g  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f MINISTRY OF HEALTH   (Zambia)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; EFAVIRENZ; EMTRICITABINE; FERRITIN; LAMIVUDINE; NEVIRAPINE; PHOSPHATE; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; ZAMBIA; BLOOD; CHEMISTRY; FOLLOW UP; PATHOLOGY; PREDICTIVE VALUE; SERUM; TREATMENT OUTCOME;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CD4 LYMPHOCYTE COUNT; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MALNUTRITION; PHOSPHATES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SERUM; SERUM ALBUMIN; TREATMENT OUTCOME; ZAMBIA;

EID: 79953732772     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-19     Document Type: Article

References (31)

1. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JS Stringer I Zulu J Levy EM Stringer A Mwango BH Chi V Mtonga S Reid RA Cantrell M Bulterys MS Saag RG Marlink A Mwinga TV Ellerbrock M Sinkala, JAMA 2006 296 782 793 10.1001/jama.296.7.782 16905784 (Pubitemid 44223102)
2. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. R Zachariah M Fitzgerald M Massaquoi O Pasulani L Arnould S Makombe AD Harries, AIDS 2006 20 2355 2360 10.1097/QAD.0b013e32801086b0 17117022 (Pubitemid 44789538)
3. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. A Johannessen E Naman BJ Ngowi L Sandvik MI Matee HE Aglen SG Gundersen JN Bruun, BMC Infect Dis 2008 8 52 10.1186/1471-2334-8-52 18430196
4. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. SD Lawn AD Harries X Anglaret L Myer R Wood, AIDS 2008 22 1897 1908 10.1097/QAD.0b013e32830007cd 18784453
5. Association of serum albumin and mortality risk. P Goldwasser J Feldman, J Clin Epidemiol 1997 50 693 703 10.1016/S0895-4356(97)00015-2 9250267 (Pubitemid 27341819)
6. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. JG Feldman DN Burns SJ Gange P Bacchetti M Cohen K Anastos M Nowicki R Delapena P Miotti, AIDS 2000 14 863 870 10.1097/00002030-200005050-00013 10839595 (Pubitemid 30303464)
7. C-reactive protein is a marker for human immunodeficiency virus disease progression. B Lau AR Sharrett LA Kingsley W Post FJ Palella B Visscher SJ Gange, Arch Intern Med 2006 166 64 70 10.1001/archinte.166.1.64 16401812 (Pubitemid 43063843)
8. Malnutrition syndromes: a conundrum vs continuum. GL Jensen B Bistrian R Roubenoff DC Heimburger, JPEN J Parenter Enteral Nutr 2009 33 710 716 10.1177/0148607109344724 19892905
9. Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. DC Macallan MA McNurlan E Milne AG Calder PJ Garlick GE Griffin, Am J Clin Nutr 1995 61 818 826 7702025
10. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. JC Melchior T Niyongabo D Henzel I Durack-Bown SC Henri A Boulier, Nutrition 1999 15 865 869 10.1016/S0899-9007(99)00210-5 10575662 (Pubitemid 29518471)
11. C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting. PK Drain R Kupka GI Msamanga W Urassa F Mugusi WW Fawzi, AIDS 2007 21 2067 2075 10.1097/QAD.0b013e32826fb6c7 17885297 (Pubitemid 47462156)
12. Elevated iron status strongly predicts mortality in West African adults with HIV infection. JM McDermid A Jaye MF Schim van der Loeff J Todd C Bates S Austin D Jeffries AA Awasana AA Whittlex A Prentice, J Acquir Immune Defic Syndr 2007 46 498 507 10.1097/QAI.0b013e31815b2d4b 18077841 (Pubitemid 350098703)
13. Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study. DC Heimburger JR Koethe C Nyirenda C Bosire JM Chiasera M Blevins AJ Munoz BE Shepherd D Potter I Zulu A Chisembele-Taylor BH Chi JS Stringer EK Kabagambe, PLoS One 5 10687 10.1371/journal.pone.0010687 20502700
14. The pathophysiology and clinical characteristics of severe hypophosphatemia. JP Knochel, Arch Intern Med 1977 137 203 220 10.1001/archinte.137.2.203 836118 (Pubitemid 9033799)
15. Refeeding syndrome: Treatment considerations based on collective analysis of literature case reports. AA Boateng K Sriram MM Meguid MA Crook, Nutrition 2010 26 156 167 10.1016/j.nut.2009.11.017 20122539
16. Serum albumin is a powerful predictor of survival among HIV-1-infected women. JG Feldman SJ Gange P Bacchetti M Cohen M Young KE Squires C Williams P Goldwasser K Anastos, J Acquir Immune Defic Syndr 2003 33 66 73 10.1097/00126334-200305010-00010 12792357 (Pubitemid 36547243)
17. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. LH Kuller R Tracy W Belloso S De Wit F Drummond HC Lane B Ledergerber J Lundgren J Neuhaus D Nixon NI Paton JD Neaton INSIGHT SMART Study Group, PLoS Med 2008 5 203 10.1371/journal.pmed.0050203 18942885
18. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. DW Krebs BH Chi Y Mulenga M Morris RA Cantrell L Mulenga J Levy M Sinkala JS Stringer, AIDS Care 2008 20 311 317 10.1080/09540120701594776 18351478 (Pubitemid 351451247)
19. RJA Little DB Rubin, Statistical Analysis with Missing Data New Jersey: Wiley 2 2002
20. Robust Locally Weighted Regression and Smoothing Scatterplots. WS Cleveland, Journal of the American Statistical Association 1979 74 829 836 10.2307/2286407
21. AS Fauci E Braunwald DL Kasper SL Hauser DL Longo JL Jameson L J, Harrison's Principles of Internal Medicine New York: McGraw-Hill Medical 17 2008
22. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. RC Kalayjian RN Machekano N Rizk GK Robbins RT Gandhi BA Rodriguez RB Pollard MM Lederman A Landay, J Infect Dis 201 1796 1805 10.1086/652750 20446847
23. Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. TC Quinn P Piot JB McCormick FM Feinsod H Taelman B Kapita W Stevens AS Fauci, JAMA 1987 257 2617 2621 10.1001/jama.257.19.2617 3494857
24. Immune activation is a dominant factor in the pathogenesis of African AIDS. Z Bentwich A Kalinkovich Z Weisman, Immunol Today 1995 16 187 191 10.1016/0167-5699(95)80119-7 7734046
25. Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program. G Rizzardini D Trabattoni M Saresella S Piconi M Lukwiya S Declich M Fabiani P Ferrante M Clerici, AIDS 1998 12 2387 2396 10.1097/00002030-199818000-00007 9875576 (Pubitemid 28558596)
26. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. MA Montano CP Nixon T Ndung'u H Bussmann VA Novitsky D Dickman M Essex, J Infect Dis 2000 181 76 81 10.1086/315185 10608753 (Pubitemid 30049035)
27. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. PM Ridker M Cushman MJ Stampfer RP Tracy CH Hennekens, N Engl J Med 1997 336 973 979 10.1056/NEJM199704033361401 9077376 (Pubitemid 27152782)
28. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. BR Clapp GM Hirschfield C Storry JR Gallimore RP Stidwill M Singer JE Deanfield RJ MacAllister MB Pepys P Vallance AD Hingorani, Circulation 2005 111 1530 1536 10.1161/01.CIR.0000159336. 31613.31 15795363 (Pubitemid 40470649)
29. A clinical study of malnutrition in Japanese prisoners of war. MA Schnitker PE Mattman TL Bliss, Ann Intern Med 1951 35 69 96 14847450
30. Serum albumin: relationship to inflammation and nutrition. BR Don G Kaysen, Semin Dial 2004 17 432 437 10.1111/j.0894-0959.2004.17603.x 15660573 (Pubitemid 40110428)
31. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. S Rosen MP Fox CJ Gill, PLoS Med 2007 4 298 10.1371/journal.pmed.0040298 17941716